CMS is targeting nearly $90 billion in federal savings over the next decade under a sweeping newly proposed anti-fraud rule that would reach across Medicare, Medicaid and the ACA marketplace.
The rule, proposed Nov. 16 and titled Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH), would tighten provider enrollment screening, expand fraud reporting requirements for Medicare Advantage plans, strengthen state-federal coordination on Medicaid oversight and give federal regulators new authority to restrict insurance agents and brokers on the ACA marketplace. CMS also said it plans to issue program integrity rulemaking on an annual basis going forward.
The proposal follows months of escalating federal fraud enforcement actions that have included billions of dollars in withheld Medicaid payments to states, provider enrollment freezes for hospices, home health agencies and durable medical equipment suppliers, and a requirement that all 50 states audit their Medicaid providers.
CMS first sought public input on the CRUSH initiative through a request for information in February, which drew more than 560 comments. Feedback on the proposed rule is due Jan. 19, 2027.
Medicare
The rule would give CMS more authority to screen out providers and suppliers before they begin billing Medicare.
Under current regulations, providers have up to 90 days to report certain changes to their enrollment information, such as shifts in ownership or practice location. The new rule would require providers to report all enrollment changes within 30 days, extending the shorter deadline to changes currently subject to a 90-day window. It would also create new grounds for denying or revoking Medicare enrollment when an owner’s identity cannot be confirmed or when CMS determines an owner poses a fraud risk. In October, HHS separately delegated the power to exclude individual providers from federal healthcare programs directly to the CMS administrator.
A separate set of provisions targets durable medical equipment suppliers, an area CMS has flagged as a persistent source of fraudulent billing within the Medicare program. The rule would require suppliers to disclose relationships with companies that provide marketing, fulfillment, wholesale or device manufacturing services, a change CMS said is designed to expose networks of interrelated fraudulent operations.
In addition, the rule would expand protections for Medicare beneficiaries against aggressive outreach from medical supply companies. Current policy prohibits unsolicited phone calls, but the proposed rule would extend that ban to text messages, social media direct messages, emails without an opt-out option and door-to-door visits.
Medicare Advantage and Part D
The proposed rule takes several steps to tighten oversight of the Medicare Advantage program, including another try at expanding the government’s authority to audit insurers and recover overpayments.
Under the current system, MA plans are expected to have internal compliance programs that identify suspicious billing by in-network providers, but CMS doesn’t require plans to report what they find. Last year, only 46% of MA and prescription drug plans voluntarily reported suspected fraud, and only 19% reported suspending payments to a provider over a credible fraud allegation. The proposed rule would make both reporting requirements mandatory across all provider and supplier types.
The rule would also require providers that bill MA plans to enroll in traditional Medicare, a change that would subject them to the same screening CMS applies under fee-for-service, including identity verification, licensure reviews, site visits and background checks. Currently, CMS relies on a preclusion list that works after a provider has already begun billing MA plans, rather than screening them upfront. If finalized, the enrollment requirement would take effect two years after the final rule is published.
Perhaps the most consequential proposal involves the Risk Adjustment Data Validation (RADV) program, CMS’ primary tool for identifying and recovering MA overpayments. Insurers receive fixed monthly payments from CMS for each enrollee, adjusted based on how sick that enrollee appears in their medical records. For years, federal investigators have found that some payers inflate those risk scores through unsupported diagnosis codes, a practice known as upcoding, in order to receive higher reimbursement. MedPAC estimated CMS would spend $84 billion more on MA enrollees in 2025 than if they were in traditional Medicare, reflecting both coding differences and favorable selection.
In 2023, CMS finalized an RADV rule that eliminated a previously announced adjustment meant to account for diagnosis errors within traditional Medicare. The rule also allowed the agency to extrapolate audit findings from a small sample of enrollees across an entire MA contract. Insurers largely opposed the changes because the combination would’ve dramatically increased their financial exposure and allowed audits retroactively to payment year 2018.
Humana then sued over the rule in September 2023, and a federal judge in Texas vacated it in September 2025, finding CMS failed to give adequate notice of the change. HHS appealed that decision in November 2025, and the Fifth Circuit began hearing oral arguments this past October.
The CRUSH rule would effectively re-propose elements of the vacated RADV rule by extrapolating audit findings back to 2018, but without applying the fee-for-service adjuster. CMS estimates the new approach would allow it to collect an average of roughly $9 billion per payment year in MA overpayments.
Medicaid and CHIP
The proposed rule would formalize several Medicaid oversight measures that have so far been carried out through administrative actions, while also closing gaps between Medicaid and Medicare’s fraud prevention frameworks.
Currently, states must suspend Medicaid payments to a provider when they find a credible allegation of fraud, but CMS has no way to directly trigger that finding. The rule would change that by allowing states to rely on a decision made by CMS or another federal agency, rather than building the case independently.
The rule would also add new grounds for denying or terminating a provider’s enrollment in the Medicaid or CHIP programs, including felony convictions and billing abuses, which matches standards already in place under Medicare. CMS said the change is meant to close a gap that has allowed providers removed from Medicare to continue billing Medicaid.
On the data side, the rule would require states to collect and use National Provider Identifiers for all eligible Medicaid and CHIP providers across enrollment, claims processing and oversight activities. CMS said the current system does not consistently track providers at the individual level, which limits its ability to identify patterns of fraud across state lines. States would also face new monthly reporting requirements on provider denials and terminations.
The rule proposes replacing the existing Medicaid Eligibility Quality Control program with a new audit structure under direct federal oversight. CMS said the current system, in place since the late 1970s, has had ongoing problems with flexibility, targeting and timeliness. Under the new structure, CMS would oversee state eligibility determinations and could impose financial penalties on states whose error rates exceed a 3% threshold.
The rule would also require providers to self-report and return Medicaid fee-for-service overpayments within 60 days.
ACA marketplace
The proposed rule would give CMS new tools to police agents and brokers on the ACA marketplace, building on efforts this year that have already resulted in mass disenrollments and an attempted broker registration freeze.
In July, the Government Accountability Office found that consumer complaints of unauthorized ACA enrollments and plan switches grew from roughly 66,500 in 2023 to nearly 300,000 in 2025. The GAO said agents and brokers had been enrolling people in coverage or switching their plans without consent to collect commissions from insurers, and that CMS lacked adequate safeguards to prevent it. In September, CMS said it had canceled policies covering more than 760,000 people that it determined were unauthorized and attempted to freeze new broker registrations, though a federal judge later lifted the freeze.
Under the proposed rule, agents and brokers with certain felony convictions or who have been excluded from other federal healthcare programs would be banned from participating in the marketplace. It would also strengthen CMS’ suspension authority by allowing the agency to immediately suspend an agent or broker based on a credible allegation of abusive conduct, rather than the current standard that requires a reasonable suspicion of fraud involving personally identifiable information.
The rule would also clarify that CMS can terminate a broker’s marketplace agreement even if that individual corrects the identified problem within 30 days. Under current regulations, brokers have a 30-day window to resolve noncompliance, which CMS said has effectively allowed repeat offenders to avoid consequences by fixing violations only after they are caught.
In addition, the rule would require agents and brokers to block access to marketplace systems from outside the U.S., including through virtual private networks that route traffic through foreign servers.
